Maternal 25(OH)D concentrations ≥40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center
Open Access
- 24 July 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (7) , e0180483
Abstract
Given the high rate of preterm birth (PTB) nationwide and data from RCTs demonstrating risk reduction with vitamin D supplementation, the Medical University of South Carolina (MUSC) implemented a new standard of care for pregnant women to receive vitamin D testing and supplementation. To determine if the reported inverse relationship between maternal 25(OH)D and PTB risk could be replicated at MUSC, an urban medical center treating a large, diverse population. Medical record data were obtained for pregnant patients aged 18–45 years between September 2015 and December 2016. During this time, a protocol that included 25(OH)D testing at first prenatal visit with recommended follow-up testing was initiated. Free vitamin D supplements were offered and the treatment goal was ≥40 ng/mL. PTB rates (<37 weeks) were calculated, and logistic regression and locally weighted regression (LOESS) were used to explore the association between 25(OH)D and PTB. Subgroup analyses were also conducted. Among women with a live, singleton birth and at least one 25(OH)D test during pregnancy (N = 1,064), the overall PTB rate was 13%. The LOESS curve showed gestational age rising with increasing 25(OH)D. Women with 25(OH)D ≥40 ng/mL had a 62% lower risk of PTB compared to those <20 ng/mL (p<0.0001). After adjusting for socioeconomic variables, this lower risk remained (OR = 0.41, p = 0.002). Similar decreases in PTB risk were observed for PTB subtypes (spontaneous: 58%, p = 0.02; indicated: 61%, p = 0.006), by race/ethnicity (white: 65%, p = 0.03; non-white: 68%, p = 0.008), and among women with a prior PTB (80%, p = 0.02). Among women with initial 25(OH)D <40 ng/mL, PTB rates were 60% lower for those with ≥40 vs. <40 ng/mL on a follow-up test (p = 0.006); 38% for whites (p = 0.33) and 78% for non-whites (p = 0.01). Maternal 25(OH)D concentrations ≥40 ng/mL were associated with substantial reduction in PTB risk in a large, diverse population of women.Keywords
This publication has 15 references indexed in Scilit:
- Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and risks of adverse birth outcomesThe American Journal of Clinical Nutrition, 2016
- Early-Pregnancy Vitamin D Deficiency and Risk of Preterm Birth SubtypesObstetrics & Gynecology, 2015
- Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: A combined analysisThe Journal of Steroid Biochemistry and Molecular Biology, 2013
- Maternal 25-Hydroxyvitamin D and Preterm Birth in Twin GestationsObstetrics & Gynecology, 2013
- A randomized trial of vitamin D supplementation in 2 community health center networks in South CarolinaAmerican Journal of Obstetrics and Gynecology, 2013
- Births: final data for 2009.2011
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectivenessJournal of Bone and Mineral Research, 2011
- Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention.2011
- The Preterm Prediction Study: Effect of gestational age and cause of preterm birth on subsequent obstetric outcomeAmerican Journal of Obstetrics and Gynecology, 1999